Literature DB >> 7872271

Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms.

N J Talley1, S L Fett, A R Zinsmeister.   

Abstract

OBJECTIVE: A link between functional bowel disease and sexual, physical, emotional, or verbal abuse remains controversial. We aimed to determine whether abuse is associated with functional bowel disease in outpatients.
METHODS: A consecutive sample of outpatients completed a validated questionnaire; 997 responded. Using standard criteria, we obtained data on symptoms, psychosocial factors, and abuse (sexual, physical, and emotional or verbal). Logistic regression analysis was used to determine whether abuse was associated with functional bowel disease (versus organic disease) and with irritable bowel syndrome (IBS)-type symptoms defined by the Manning criteria. Adjustments were made for age, gender, marital status, education level, psychological distress, and social support.
RESULTS: Of those with a physician-based diagnosis of functional bowel disease (n = 440), 22% reported some form of abuse (13% sexual and/or physical abuse), compared with those with organic disease (n = 557), 16% of whom reported some form of abuse; this difference was not significant. However, abused patients were significantly more likely to report IBS-type symptoms than those who did not report a history of abuse (odds ratio = 1.7, 95% confidence interval = 1.2, 2.5).
CONCLUSION: Outpatients who report abuse are more likely to have IBS-type symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7872271

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  41 in total

1.  Colonic motor function in humans is not affected by gender.

Authors:  E E Soffer; K Kongara; J P Achkar; J Gannon
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

2.  IRRITABLE BOWEL SYNDROME: Relationships with Abuse in Childhood.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 May-Jun

3.  Women and functional dyspepsia.

Authors:  Kate Napthali; Natasha Koloski; Marjorie M Walker; Nicholas J Talley
Journal:  Womens Health (Lond)       Date:  2016-02-22

4.  Long-term physical health consequences of childhood sexual abuse: a meta-analytic review.

Authors:  Leah Irish; Ihori Kobayashi; Douglas L Delahanty
Journal:  J Pediatr Psychol       Date:  2009-12-18

Review 5.  Trauma and the gut: interactions between stressful experience and intestinal function.

Authors:  R Stam; L M Akkermans; V M Wiegant
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

6.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

7.  Relationship of abuse history and other risk factors with obesity among female gastrointestinal patients.

Authors:  Huanguang Jia; Jim Z Li; Jane Leserman; Yuming Hu; Douglas A Drossman
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 9.  Measuring the symptoms of pediatric constipation and irritable bowel syndrome with constipation: expert commentary and literature review.

Authors:  Robert A Arbuckle; Robyn T Carson; Linda Abetz-Webb; Jeffrey Hyams; Carlo Di Lorenzo; Barbara E Lewis; Elizabeth Gargon; Caroline Kurtz; Steven J Shiff; Jeffrey M Johnston
Journal:  Patient       Date:  2014       Impact factor: 3.883

10.  Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.